Certis Therapeutics

Certis Therapeutics is a healthcare technology startup that has developed a unique approach to minimally invasive therapy solutions. The company's technology is based on real-time MRI guidance, which allows for more precise and safe thermal ablation treatments. Thermal ablation is a procedure that uses heat to destroy abnormal cells, such as cancer cells. However, the lack of proper monitoring and control tools can lead to incomplete treatments or unintentional damage to healthy tissues. Certis Therapeutics aims to solve this problem by providing unprecedented accuracy in delivering thermal energy.

The company develops both software and hardware devices. Their software includes fast image reconstruction and 3D real-time temperature mapping, which helps in monitoring the procedure and ensuring the accuracy of the treatment. They also develop hardware devices that are designed to achieve accurate ablation, a process that destroys abnormal cells.

Certis Therapeutics' technology is versatile and can be applied to various thermal techniques such as radiofrequencies, microwaves, laser, and focused ultrasound thermal ablation. It can handle organs as mobile as the heart and liver and has been used in academic research for various pathologies including cancer, cardiac arrhythmias, and neurological disorders.

The company's business model is likely based on selling their software and hardware solutions to healthcare providers. They also work on improving the clinical workflow to ensure maximum usability, safety, and efficiency for medical users.

Keywords: Healthcare Technology, Minimally Invasive Therapy, Real-Time MRI Guidance, Thermal Ablation, Software Development, Hardware Development, Precision Medicine, Cancer Treatment, Cardiac Arrhythmias Treatment, Neurological Disorders Treatment.